Back to Trades
Brady James Aloysius
DirectorCIK 0001916987
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 4
- Buy transactions
- 0
- Sell transactions
- 2
- Companies
- 2
- Active
- 2025–2026
Brady James Aloysius, Director, has filed 4 SEC reports (2025–2026), spread across 2 companies, totaling $1.2M in disclosed volume. Weighing $0 bought versus $70.9K sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
4 loaded
| Jun 5 | XERS Xeris Biopharma Holdings, Inc. | Brady James Aloysius | Director | Grant | $202.9K |
| Apr 1 | XERS Xeris Biopharma Holdings, Inc. | Brady James Aloysius | Director | Sell | $60.0K |
| Oct 8 | VRNA Verona Pharma plc | Brady James Aloysius | Director | Exercise | $894.0K |
| Aug 5 | VRNA Verona Pharma plc | Brady James Aloysius | Director | Sell | $10.8K |
4 filings